D.A. Davidson & CO. Acquires 2,405 Shares of Lam Research Corporation $LRCX

D.A. Davidson & CO. boosted its holdings in shares of Lam Research Corporation (NASDAQ:LRCX) by 2.3% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 105,407 shares of the semiconductor company’s stock after purchasing an additional 2,405 shares during the period. D.A. Davidson & CO.’s holdings in Lam Research were worth $10,260,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in shares of Lam Research by 6.9% in the 1st quarter. Vanguard Group Inc. now owns 129,152,102 shares of the semiconductor company’s stock valued at $9,389,358,000 after purchasing an additional 8,364,375 shares during the period. Invesco Ltd. raised its stake in shares of Lam Research by 2.8% in the 1st quarter. Invesco Ltd. now owns 17,330,771 shares of the semiconductor company’s stock valued at $1,259,947,000 after purchasing an additional 472,636 shares during the period. Nordea Investment Management AB raised its stake in shares of Lam Research by 34.1% in the 2nd quarter. Nordea Investment Management AB now owns 10,594,574 shares of the semiconductor company’s stock valued at $1,029,210,000 after purchasing an additional 2,692,189 shares during the period. Goldman Sachs Group Inc. raised its stake in shares of Lam Research by 25.8% in the 1st quarter. Goldman Sachs Group Inc. now owns 9,536,708 shares of the semiconductor company’s stock valued at $693,319,000 after purchasing an additional 1,953,221 shares during the period. Finally, Charles Schwab Investment Management Inc. raised its stake in shares of Lam Research by 4.9% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 8,900,506 shares of the semiconductor company’s stock valued at $647,067,000 after purchasing an additional 418,077 shares during the period. 84.61% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several analysts have issued reports on LRCX shares. Erste Group Bank started coverage on Lam Research in a research note on Thursday, August 14th. They issued a “buy” rating on the stock. Oppenheimer lifted their price target on Lam Research from $110.00 to $120.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. The Goldman Sachs Group lifted their target price on Lam Research from $115.00 to $160.00 and gave the company a “buy” rating in a research report on Wednesday, October 8th. Mizuho set a $162.00 price target on Lam Research and gave the company an “outperform” rating in a research report on Thursday, October 16th. Finally, Raymond James Financial raised their price target on Lam Research from $90.00 to $110.00 and gave the company an “outperform” rating in a research note on Thursday, July 31st. One analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating and eight have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Lam Research currently has an average rating of “Moderate Buy” and a consensus target price of $128.04.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $141.25 on Thursday. The business’s 50 day moving average price is $121.38 and its two-hundred day moving average price is $98.38. The company has a market cap of $178.12 billion, a PE ratio of 33.95, a price-to-earnings-growth ratio of 1.76 and a beta of 1.84. The company has a quick ratio of 1.55, a current ratio of 2.21 and a debt-to-equity ratio of 0.38. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $153.70.

Lam Research (NASDAQ:LRCX) last announced its quarterly earnings results on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, topping analysts’ consensus estimates of $1.22 by $0.04. The firm had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.23 billion. Lam Research had a return on equity of 58.17% and a net margin of 29.07%.The business’s revenue was up 27.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.86 earnings per share. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. On average, analysts predict that Lam Research Corporation will post 3.71 EPS for the current year.

Lam Research Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Wednesday, October 15th. Shareholders of record on Wednesday, September 24th were given a dividend of $0.26 per share. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. This is a boost from Lam Research’s previous quarterly dividend of $0.23. The ex-dividend date of this dividend was Wednesday, September 24th. Lam Research’s dividend payout ratio (DPR) is presently 25.00%.

Insiders Place Their Bets

In other Lam Research news, SVP Vahid Vahedi sold 52,190 shares of the business’s stock in a transaction that occurred on Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the transaction, the senior vice president owned 251,047 shares of the company’s stock, valued at $34,870,428.30. The trade was a 17.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.31% of the stock is currently owned by company insiders.

Lam Research Profile

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.